Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN15529655Phase 2Completed
Phase 2, randomised, double-blind trial of melatonin (2 arms), sponsored by University of Aberdeen. Primary endpoint: Trial completion feasibility. Started Apr 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN15529655.